StockGlow

ImmunityBio, Inc. (26CA.F)

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases.

6.50+0.01%Healthcare
Compare 26CA.F with
StockGlow Score
61
Leaning Bullish
BearishBullish
1 year ago+221.6%

The outlook

ImmunityBio, Inc. currently reads as leaning bullish based on mixed vs its moving averages, 55% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range55% of the way from its 52-week low to high
Market cap
$6.81B
52-wk high
10.40
52-wk low
1.68
50-day avg
6.67
200-day avg
5.17
Trailing P/E
—

Similar stocks

26CA.MUImmunityBio Inc$6.44+1.10%41L.FLaboratorios Farmaceuticos Rovi, S.A.$59.45+0.00%2LB.FIovance Biotherapeutics, Inc.$3.93-1.01%38I.FIntellia Therapeutics, Inc.$9.30+1.53%DR6.FACADIA Pharmaceuticals Inc.$23.02+0.61%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy